Market Snapshot

BSE Sensex: 82498.14 -1.48%
BSE 500: 36523.88 -1.45%
BSE 200: 11551.17 -1.49%
BSE 100: 26676.04 -1.49%
BSE BANKEX: 68274.85 -1.27%
BSE IT: 31359.68 -0.84%
Nifty 50: 25454.35 -1.41%
Nifty 500: 23297.45 -1.47%
Nifty 200: 14211.95 -1.51%
Nifty 100: 26090.7 -1.49%
Nifty Midcap 100: 59227.65 -1.59%
Nifty Small 100: 17020.35 -1.27%
Nifty IT: 32319.4 -1.07%
Nifty PSU Bank: 9505.95 -1.24%

News:

Meta Infotech bags orders wort...
Hindustan Unilever board OKs R...
DCX Systems secures orders wor...
Alembic Pharma slumps after re...
Puravankara launches premium r...

Suven Life Sciences Ltd Share Price – NSE / BSE
Healthcare, Small Cap

Invest

19 Feb 2026 | 03:59 PM

151.25

-1.60 (-1.05%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

27.74%

Return (1Y)

Beaten BSE Healthcare by 20.42%
More Volatile

3.5%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.62%
Not so consistent

4/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

303

103

News & Announcements

Suven Life Sciences allots 44.77 lakh equity shares on conversion of warrants
22 days ago

Suven Life Sciences allots 44.77 lakh equity shares on conversion of warrants

29 - Jan - 2026 12:00 | 22 days ago

Suven Life Sciences has allotted 44,77,612 equity shares on preferential basis up on conversion of equivalent number of convertible warrants. Consequently, the paid up equity share capital has increased to 23,19,51,819 equity shares of Re 1 each.
Powered by Capital Market - Live News
Suven Life Sciences reports consolidated net loss of Rs 101.92 crore in the December 2025 quarter
22 days ago

Suven Life Sciences reports consolidated net loss of Rs 101.92 crore in the December 2025 quarter

29 - Jan - 2026 12:00 | 22 days ago

Net Loss of Suven Life Sciences reported to Rs 101.92 crore in the quarter ended December 2025 as against net loss of Rs 39.12 crore during the previous quarter ended December 2024. Sales rose 74.53% to Rs 2.81 crore in the quarter ended December 2025 as against Rs 1.61 crore during the previous quarter ended December 2024.

Particulars Quarter Ended
Dec. 2025 Dec. 2024 % Var.

Sales 2.81 1.61 75

OPM % -3677.94 -2435.40 -

PBDT -100.58 -37.58 -168

PBT -101.92 -39.12 -161

NP -101.92 -39.12 -161

Powered by Capital Market - Live News
Suven Life Sciences to declare Quarterly Results
28 days ago

Suven Life Sciences to declare Quarterly Results

23 - Jan - 2026 12:00 | 28 days ago

Suven Life Sciences will hold a meeting of the Board of Directors of the Company on 29 January 2026.
Powered by Capital Market - Live News
Suven Life Sciences reports consolidated net loss of Rs 77.31 crore in the September 2025 quarter
101 days ago

Suven Life Sciences reports consolidated net loss of Rs 77.31 crore in the September 2025 quarter

11 - Nov - 2025 12:00 | 101 days ago

Net Loss of Suven Life Sciences reported to Rs 77.31 crore in the quarter ended September 2025 as against net loss of Rs 49.64 crore during the previous quarter ended September 2024. Sales declined 64.20% to Rs 0.92 crore in the quarter ended September 2025 as against Rs 2.57 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 0.92 2.57 -64

OPM % -8670.65 -2031.52 -

PBDT -75.99 -48.19 -58

PBT -77.31 -49.64 -56

NP -77.31 -49.64 -56

Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Suven Life Sciences Ltd has decreased by -9.19% since past 3 Months
FII shareholding in Suven Life Sciences Ltd has increased by 216.9% since past 1 Year
MF shareholding in Suven Life Sciences Ltd has increased by 96.79% since past 1 Year
Promoter shareholding in Suven Life Sciences Ltd has decreased by -4.13% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	2.81	1.61	75
OPM %	-3677.94	-2435.40	-
PBDT	-100.58	-37.58	-168
PBT	-101.92	-39.12	-161
NP	-101.92	-39.12	-161

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.92	2.57	-64
OPM %	-8670.65	-2031.52	-
PBDT	-75.99	-48.19	-58
PBT	-77.31	-49.64	-56
NP	-77.31	-49.64	-56

General Notifications

My Notifications

Research Notifications

Suven Life Sciences Ltd Share Price – NSE / BSE Healthcare, Small Cap

151.25 -1.60 (-1.05%)

News & Announcements

Price vs Volume

Stock Trivia

Suven Life Sciences Ltd Share Price – NSE / BSE
Healthcare, Small Cap

151.25

-1.60 (-1.05%)